As expected, ABHD5 deficiency-suppressed CRC cell proliferation (Fig. 5i) and tumour growth (Fig. 5j) were rescued by additional C/EBPɛ knockdown in RAW cells. Here, ABHD5 is linked to colorectal carcinoma.